Usefulness of the Japan Esophageal Society Classification of Barrett's Esophagus for Diagnosing the Lateral Extent of Superficial Short-Segment Barrett's Esophageal Cancer

被引:2
|
作者
Suzuki, Yugo [1 ]
Okamura, Takayuki [1 ]
Matsui, Akira [1 ]
Hayasaka, Junnosuke [1 ]
Nomura, Kosuke [1 ]
Kikuchi, Daisuke [1 ]
Hoteya, Shu [1 ]
机构
[1] Toranomon Gen Hosp, Dept Gastroenterol, Tokyo, Japan
关键词
Barrett's esophagus; Esophageal cancer; Endoscopic submucosal dissection; Magnifying endoscopy; ENDOSCOPIC SUBMUCOSAL DISSECTION; SPECIALIZED INTESTINAL METAPLASIA; BAND IMAGING ENDOSCOPY; HIGH-GRADE DYSPLASIA; ESOPHAGOGASTRIC JUNCTION; MAGNIFICATION ENDOSCOPY; MUCOSAL MORPHOLOGY; ACETIC-ACID; ADENOCARCINOMA; VALIDATION;
D O I
10.1159/000525586
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: The Japanese guidelines for endoscopic submucosal dissection (ESD) of Barrett's esophageal adenocarcinoma (BEA) recommend image-enhanced magnifying endoscopic examination for diagnosing the lateral extent of superficial esophageal adenocarcinoma. The Japan Esophageal Society Barrett's Esophagus (JES-BE) classification is proposed recently and is useful in terms of diagnostic accuracy. In this study, we retrospectively examined the usefulness of the JES-BE classification for differential diagnosis and determination of the extent of BEA originating in short-segment Barrett's esophagus. Methods: The study reviewed 51 lesions which underwent ESD for BEA. The circumference of the esophagogastric junction was divided into four parts, and the lesions were divided into those in the right anterior portion (RA group; n = 33) and those in other portions (non-RA group; n = 18). Clinicopathological characteristics and clinical outcomes were compared between the two groups. Results: JES-BE classification findings as "dysplasia" were seen in 48 out of 51 (94.1%) BEA lesions retrospectively. There was no significant difference in histological type, tumor depth, lymphovascular invasion, or the proportion of tumors with a positive or unknown horizontal or vertical margin status between the groups. The proportion of tumors with type 0-I morphology was significantly higher in the RA group (p = 0.023). The tumor size was significantly greater in the RA group (p = 0.034). According to the JES-BE classification, 31 lesions (93.9%) in the RA group and 17 lesions (94.4%) in the non-RA group were diagnosed as dysplasia. There was also no significant difference in the rate of consistency between the endoscopic and histopathological findings on the lateral extent of the lesion (90.9% vs. 83.3%; p = 0.612). Discussion/Conclusions: The JES-BE classification may be useful for determining the extent of BEA.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 50 条
  • [31] Barrett?s Esophagus and Esophageal Adenocarcinoma: A Histopathological Perspective
    Zyla, Roman E.
    Kalimuthu, Sangeetha N.
    THORACIC SURGERY CLINICS, 2022, 32 (04) : 413 - 424
  • [32] Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer
    Samuel B. Keeley
    Arjun Pennathur
    William Gooding
    Rodney J. Landreneau
    Neil A. Christie
    James Luketich
    Annals of Surgical Oncology, 2007, 14 : 2406 - 2410
  • [33] Photodynamic therapy with curative intent for Barrett's Esophagus with high grade dysplasia and superficial esophageal cancer
    Keeley, Samuel B.
    Pennathur, Arjun
    Gooding, William
    Landreneau, Rodney J.
    Christie, Nell A.
    Luketich, James
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (08) : 2406 - 2410
  • [35] Barrett's Esophagus and Esophageal Adenocarcinoma
    Bresalier, Robert S.
    ANNUAL REVIEW OF MEDICINE, 2009, 60 : 221 - 231
  • [36] Endoscopic Treatment for Barrett’s Esophagus and Early Esophageal Cancer
    Kenneth K. Wang
    Journal of Gastrointestinal Surgery, 2010, 14 : 946 - 947
  • [37] Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus
    Vanessa W Davis
    Daniel E Schiller
    Dean Eurich
    Michael B Sawyer
    World Journal of Surgical Oncology, 10
  • [38] The Horizon of Screening for Barrett's Esophagus and Esophageal Cancer
    Tan, W. Keith
    Fitzgerald, Rebecca C.
    TECHNIQUES AND INNOVATIONS IN GASTROINTESTINAL ENDOSCOPY, 2023, 25 (02): : 146 - 156
  • [39] Clinical characteristics may distinguish patients with esophageal adenocarcinoma arising from long- versus short-segment Barrett's esophagus
    Iwaya, Yugo
    Shimamura, Yuto
    Mosko, Jeffrey D.
    Kandel, Gabor
    Kortan, Paul P.
    May, Gary R.
    Marcon, Norman E.
    Teshima, Christopher W.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (10) : 1470 - 1474
  • [40] Barrett's esophagus with high grade dysplasia is associated with non-esophageal cancer
    Bar, Nir
    Schwartz, Naama
    Nissim, Michal
    Fliss-Isacov, Naomi
    Zelber-Sagi, Shira
    Kariv, Revital
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (39) : 4472 - 4481